off-label

Hydroxychloroquine, Pentoxifylline, and Colchicine: Off-Label is ON in Dermatology
Hydroxychloroquine, Pentoxifylline, and Colchicine: Off-Label is ON in Dermatology!
by NEXT STEPS IN DERM TEAM on
So many diseases, so few FDA approved indications. Between the mind-numbing time and cost from bench to bottle, it is no surprise that dermatologists, as masters of the integument are the off-label bandits, marrying their wealth of knowledge on the pathophysiology of skin diseases to the mechanisms by which medications work to create an evidenced-based armament of therapies for both common and rar …

Continue reading "Hydroxychloroquine, Pentoxifylline, and Colchicine: Off-Label is ON in Dermatology"

Dos & Don’ts of Industry Relationships
industry relationships in dermatology
by Neal Bhatia, MD on
Unfortunately for many residency graduates, a lot of the decisions regarding interactions with industry such as pharmaceutical and medical device sales forces have been made into policies. These are often parallel to the strictures of parents attempting to shelter their children from what is socially perceived as “evil” or “influential,” and in many instances has led to the development …

Continue reading "Dos & Don’ts of Industry Relationships"